We at EMPE are continuing to grow and are now happy to welcome three more people to the team! Dr. Sanjeev Kumar Gupta is an accomplished QMS, Regulatory and Technical professional having 25 years of experience in the field of Medical Device and In Vitro Diagnostic Devices. He holds a doctorate in Biotechnology from IIT-Roorkee & […]
EMPE Diagnostics is growing and we would like to give a warm welcome to some new employees. David Herthnek (CSO) holds a MSc in Biotechnology from Linköping University and completed his PhD in Molecular Biology on diagnostic method development at the Swedish National Veterinary Institute. David started his career as a researcher and worked for […]
Their Majesties, King Carl XVI Gustaf and Queen Silvia of Sweden visited India with an official delegation on the occasion of ‘India-Sweden Year of Health’, celebrating 10 years of Health Cooperation. Swecare’s video (https://lnkd.in/d5HBk4d) captured the most important moments, in the last 10 years. It is absolutely a great honour for EMPE diagnostics to make […]
Our CEO, Dr. Pavan Asalapuram has presented a poster about the clinical performance validations of our first product, mfloDX® miniMDR-TB test kit at the 2019 World Conference on Access to Medical Products Achieving the SDGs 2030 organised by India and WHO. It was great when the Director General of ICMR, Indian Ministry of Health, visited […]
Professor Sven Hoffner, our advisor presented a poster about the clinical performance validations of our first product, mfloDX® miniMDR-TB test kit at the 50th Union World Conference on Lung Health will take place in Hyderabad, India.
EMPE diagnostics has offered an industrial project to a group of Applied Biotechnology MSc students from Uppsala University as a part of their Innovation Management and Entrepreneurship program. Supervised by the core team of EMPE, the students stepped into shoes of young entrepreneurs and analyzed the Chinese market as a potential entry point for EMPE. […]
We presented our innovation and products at Vitalis 2019. Great Swedish venue and wide Nordic audience! Would you like to know more about the current activities at EMPE Diagnostics? Read about us at our associate, Sciety’s page:: https://lnkd.in/dEVB7mt.
Another great moment for EMPE Diagnostics when the CEO, Pavan Asalapuram announced the company’s first rapid detection test kit for MDR-TB, in front of Ms. Lena Hallengren (Minister for Health and Social Affairs Sweden), Mrs. Preeti Sudan (Secretary, Ministry of Health & Family Welfare, Government of India), and Dr. Balram Bargava (Director-General at the Indian […]
The recently awarded INNOVA4TB project is an international and intersectoral consortium that combines research institutions, clinicians, as well as small and medium-size enterprises (SMEs) for the management of M/XDR-TB from high and medium/low Tuberculosis (TB) incidence countries. The kickoff meeting was held on 24-25 Jan. 2019 at IGTP, Badalona. More details can be found at […]
Marie Skłodowska-Curie Actions Horizon 2020 RISE program has granted 1.3 million euros from the development of new methods of diagnosis and treatment of tuberculosis in a network project called Innovation in Tuberculosis – INNOVA4TB. We are happy to be a part of INNOVA4TB project, a collaborative initiative between 12 institutions from 6 countries (Spain, Sweden, […]
Foundation for Innovative New Diagnostics, FIND. As stated on FINDs website “Diagnosis is the first step on the path to treatment and the foundation of disease control and prevention”. FIND focuses on providing diagnostic solutions where they are needed, provides guidelines, policies as well as providing understanding of the diagnostic value in the community. EMPE […]
It was a great honor to represent Sweden and present our unique diagnostic solutions for the early-stage detection of bacterial infections and rapid genotyping of multidrug-resistant tuberculosis in the 2nd WHO conference held in New Delhi! A hearty thanks to all our Team Sweden, including Swedish Embassy, SweCare Foundation, Swedish Medtech, EMPE Diagnostics AB, ApiRays […]
We are entering India! Happy present our experience at “Entering markets outside EU – CB Health Access” seminar in Stockholm.
We are overwhelmed for the recognition by SwedenBIO that launched the Precision Medicine – The Swedish Industry Guide 2018! SwedenBIO has launched a major new report representing the first effort to map the Swedish Precision Medicine Industry Landscape and showcase precision medicine companies in Sweden to the global life science community.
InnoHEALTH 2017 is the second in the series of InnoHEALTH annual conferences in India, building on the success of InnoHEALTH 2016 which saw 200 participants from the World Health Innovation Network, Canada, Talent grid Ventures, Singapore, ScanBalt Forum, and Europe. The focus of this conference is to bring together the ‘innovations in healthcare’. EMPE Diagnostics […]
Swecare is a Swedish Govt. initiative that helps interactions between academia and public and private sectors, to join forces toward enhanced export and internationalization of Swedish health care and life sciences. EMPE Diagnostics is the only Molecular Diagnostic company among 9 companies that were selected to participate in the Central Baltic Health Access initiated by […]
We are happy to announce that EMPE Diagnostics has been selected for the round-table presentation under the topic future diagnostics! Come and meet us at the 38:th Annual European Society of Mycobacteriology Congress at Šibenik, Croatia!
We are happy to announce that EMPE Diagnostics is partnering with the Swedish company, Q-linea AB who has years of experience in developing rapid diagnostics! Q-linea’s fully automated solutions cut the diagnostic time for sepsis and deliver clinically-actionable results in hours instead of days.
With immense of optimism and confidence, we have agreed to perform a multi-national clinical evaluation for the assessment of our first product, the mfloDx® MDR-TB test. The product will be validated in at least seven WHO sponsored Supernational Reference Laboratories in Europe and Asia. The clinical evaluation is scheduled to start in Jan. 2018.
It is our pleasure to announce that EMPE has received a collaborative research grant to develop a new RCA-ADT rapid detection platform for diarrhoeagenic E. coli and Vibrio Cholerae. The consortium includes University of Loughborough (UK), University of Cambridge (UK), International Centre for Diarrhoeal Disease Research (Bangladesh) and Stockholm University (Sweden).
We are happy to announce the employment of Mr. Jeanpierre Salas, a Biotechnical Engineer from the famous Royal Institute of Technology. Jeanpierre will work on the technical aspects of assay integration and lateral-flow cassette assembling dynamics. Welcome Jeanpierre!